HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Acne study

This article was originally published in The Rose Sheet

Executive Summary

Acne is an emotionally distressing disease that can cause anger and frustration in adolescents and is often underestimated by parents, James Campbell, MD, Dartmouth Medical School, concludes in a study presented at the American Academy of Dermatology meeting in New York City July 28-Aug. 1. Acne affects about 85% of young adults and has more social ramifications than perhaps any other skin disease, findings state. Study surveyed 504 acne-prone teens ages 12-17 and 500 parents of teens 12-17 who experience occasional to severe acne. Teens with more severe acne were shown to experience a higher level of duress and anger, while parents of these teens were less aware of their feelings. While two-thirds of parents said they feel supportive towards their children with acne, less than half of the children agreed...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012349

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel